Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.985 USD | -0.42% | -10.73% | +1.87% |
Feb. 27 | North American Morning Briefing : Stock Futures -2- | DJ |
Feb. 26 | Citigroup Adjusts Price Target on Cogent Biosciences to $13 From $11, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.33M | Capitalization | 575M |
---|---|---|---|---|---|
Net income 2024 * | -220M | Net income 2025 * | -232M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 434 x |
P/E ratio 2024 * |
-3
x | P/E ratio 2025 * |
-3.01
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.68% |
Latest transcript on Cogent Biosciences, Inc.
1 day | -8.10% | ||
1 week | -9.08% | ||
Current month | -10.57% | ||
1 month | +3.98% | ||
3 months | +35.67% | ||
6 months | -31.16% | ||
Current year | +2.21% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Robbins
CEO | Chief Executive Officer | 48 | 20-10-22 |
John Green
DFI | Director of Finance/CFO | 43 | 18-05-31 |
Rachael Easton
CTO | Chief Tech/Sci/R&D Officer | - | 22-11-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 19-07-25 |
Matthew Ros
BRD | Director/Board Member | 57 | 19-07-25 |
Todd Shegog
BRD | Director/Board Member | 59 | 21-02-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 237 M€ | +1.04% | - | |
0.04% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 5.97 | -0.67% | 333 327 |
24-04-25 | 6.01 | -8.10% | 1,212,019 |
24-04-24 | 6.54 | -6.03% | 1,775,037 |
24-04-23 | 6.96 | -2.25% | 1,209,832 |
24-04-22 | 7.12 | +6.11% | 891,876 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.21% | 575M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- COGT Stock